Jane Street
FATE icon

Jane Street’s Fate Therapeutics FATE Stock Holding History

Jane Street’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
94,400
+79,800
+547% +$148K ﹤0.01% 9568
2026
Q1 		$17.5K Buy
+14,600
New +$17.8K ﹤0.01% 11214
2025
Q4 		– Sell
-12,800
Closed -$16.1K – 11482
2025
Q3 		$16.1K Buy
+12,800
New +$13.8K ﹤0.01% 10555
2023
Q3 		– Sell
-10,100
Closed -$48.1K – 8837
2023
Q2 		$48.1K Buy
+10,100
New +$55.7K ﹤0.01% 8216
2022
Q4 		– Sell
-36,400
Closed -$816K – 9396
2022
Q3 		$816K Buy
36,400
+12,300
+51% +$355K ﹤0.01% 5803
2022
Q2 		$597K Buy
24,100
+3,500
+17% +$96.6K ﹤0.01% 6420
2022
Q1 		$799K Sell
20,600
-55,200
-73% -$2.14M ﹤0.01% 6588
2021
Q4 		$4.43M Buy
75,800
+68,700
+968% +$3.89M ﹤0.01% 3044
2021
Q3 		$421K Buy
7,100
+900
+15% +$70.6K ﹤0.01% 7595
2021
Q2 		$538K Sell
6,200
-5,800
-48% -$467K ﹤0.01% 7091
2021
Q1 		$989K Buy
12,000
+8,700
+264% +$834K ﹤0.01% 5482
2020
Q4 		$300K Buy
+3,300
New +$205K ﹤0.01% 6418
2020
Q3 		– Sell
-8,900
Closed -$305K – 7346
2020
Q2 		$305K Buy
+8,900
New +$265K ﹤0.01% 5806

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jane Street's FATE Position: Q2 2026 in Review

Jane Street increased its Fate Therapeutics (FATE) stake by 59% in Q2 2026, buying an estimated $703K and bringing the position to 1,027,007 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #4628.

Jane Street first reported a position in FATE in Q1 2014 and has held it in 33 quarters since. The position peaked at $5.77M in Q4 2020. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Jane Street held 1,027,007 shares of Fate Therapeutics worth $2.77M as of Q2 2026.
  • Jane Street bought 380,028 Fate Therapeutics shares in Q2 2026, an estimated $703K.
  • Fate Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4628 holding.
  • Jane Street first reported a position in Fate Therapeutics in Q1 2014 and has held it in 33 quarters since.
  • Jane Street's Fate Therapeutics position peaked at $5.77M in Q4 2020.
  • 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.